Free Trial
NASDAQ:RADX

Radiopharm Theranostics Limited - American Depositary Shares (RADX) Stock Price, News & Analysis

$4.88 +0.16 (+3.39%)
As of 05/29/2025 03:59 PM Eastern

About Radiopharm Theranostics Limited - American Depositary Shares Stock (NASDAQ:RADX)

Key Stats

Today's Range
$4.80
$5.20
50-Day Range
N/A
52-Week Range
$3.50
$50.82
Volume
27,419 shs
Average Volume
141,006 shs
Market Capitalization
$36.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Strong Buy

Company Overview

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.

Receive RADX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Radiopharm Theranostics Limited - American Depositary Shares and its competitors with MarketBeat's FREE daily newsletter.

RADX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

RADX Stock Analysis - Frequently Asked Questions

Radiopharm Theranostics Limited - American Depositary Shares' stock was trading at $4.00 on January 1st, 2025. Since then, RADX stock has increased by 22.0% and is now trading at $4.88.
View the best growth stocks for 2025 here
.

Radiopharm Theranostics Limited - American Depositary Shares' top institutional shareholders include Affinity Asset Advisors LLC (0.86%).

Shares of RADX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:RADX
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.00
High Stock Price Target
$12.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+145.9%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.68 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$36.63 million
Optionable
N/A
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:RADX) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners